ABEONA THERAPEUTICS INC. (ABEO) Financial Statements
ABEONA THERAPEUTICS INC. (ABEO) reported trailing twelve-month revenue of $25.5M (up 119.7% year on year) and net income of -$62.9M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$81.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ABEOABEONA THERAPEUTICS INC.Follow ABEO — free
—
Price chart with a free account
- Market cap
- 251.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.8 | 4.4 | 2.0 | 0.9 | 1.0 | 0.9 | 0.8 | 3.0 | 10.0 | 3.0 | 1.4 | 3.5 | 5.8 | 25.5 | |
| Gross profit | 1.7 | 4.1 | 1.9 | 0.9 | — | — | — | — | — | — | — | — | 4.3 | — | |
| Research & development | 3.6 | 2.0 | 0.9 | 0.3 | 4.7 | 10.7 | 17.0 | 38.7 | 30.1 | 38.7 | 29.0 | 31.1 | 26.8 | 25.5 | |
| Operating income | -7.9 | -4.3 | -3.8 | -3.1 | -18.5 | -23.9 | -27.8 | -58.2 | -81.4 | -89.8 | -50.9 | -47.1 | -89.4 | -83.6 | |
| Pre-tax income | -2.5 | -10.5 | 4.4 | -26.8 | -14.5 | -21.9 | -27.3 | -56.7 | — | — | — | — | 71.3 | -78.3 | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | 0.1 | — | |
| Net income | -2.5 | -10.5 | 4.4 | -26.8 | -14.5 | -21.9 | -27.3 | -56.7 | -84.2 | -84.9 | -39.7 | -54.2 | 71.2 | -62.9 | |
| Diluted EPS ($) | -0.22 | -0.52 | 3.04 | -15.26 | -0.53 | -0.64 | -0.66 | -1.19 | -0.91 | -0.86 | -5.53 | -2.53 | 1.01 | -1.13 | |
| Diluted shares (mn) | — | — | 0.5 | 1.9 | — | — | — | — | — | — | 7.9 | 21.4 | 66.1 | — |
USD millions · SEC XBRL
ABEONA THERAPEUTICS INC. — questions
- What is ABEONA THERAPEUTICS INC.'s revenue?
- $25.5M over the twelve months to 2026-06-30, up 119.7% year on year, from its 10-Q and 10-K filings.
- What is ABEONA THERAPEUTICS INC.'s net income?
- -$62.9M over the twelve months to 2026-06-30.
- What is ABEONA THERAPEUTICS INC.'s free cash flow?
- -$81.5M over the twelve months to 2026-06-30.
- What are ABEONA THERAPEUTICS INC.'s diluted earnings per share?
- $-1.13 over the twelve months to 2026-06-30.
Every figure on this page comes from ABEONA THERAPEUTICS INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.